Crossmark

Complete Response Following Treatment with Olaparib in a Patient with BRCA-Mutant High-Grade Serous Ovarian Cancer and Central Nervous System Metastases

Crossref DOI link: https://doi.org/10.1007/s40944-023-00710-y

Published Online: 2023-04-15

Published Print: 2023-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

AlSendi, Maha https://orcid.org/0000-0003-2806-7568
Madan, Ali

Malik, Hanadi
License Information

Text and Data Mining valid from 2023-04-15

Version of Record valid from 2023-04-15
More Information

Article History

Received: 15 December 2022

Revised: 25 January 2023

Accepted: 6 February 2023

First Online: 15 April 2023

Declarations

:

: Authors report no conflict of interest.

Document is current

Any future updates will be listed below